Silver-Russell Syndrome Due to Maternal Uniparental Disomy of Chromosome 11

Oncology·MeSH: Spinocerebellar Ataxia 10

Prevalence

0.1 / 100K

0 drugs in development·0 companies·1 clinical trial

Frequently asked questions

How many clinical trials target Silver-Russell Syndrome Due to Maternal Uniparental Disomy of Chromosome 11?

There are 1 clinical trial targeting Silver-Russell Syndrome Due to Maternal Uniparental Disomy of Chromosome 11 tracked by BioSniper.

What is the prevalence of Silver-Russell Syndrome Due to Maternal Uniparental Disomy of Chromosome 11?

The estimated prevalence of Silver-Russell Syndrome Due to Maternal Uniparental Disomy of Chromosome 11 is approximately 0.1 per 100,000 population.

Deep-dive into Silver-Russell Syndrome Due to Maternal Uniparental Disomy of Chromosome 11

Full trial data, competitive analysis, and AI-powered pipeline tracking.

Start Free Analysis
    Silver-Russell Syndrome Due to Maternal Uniparental Disomy of Chromosome 11 — Drugs in Development & Clinical Trials | BioSniper